One of the world's leading pharmaceutical companies is to create 200 permanent jobs through a multi-million euro investment in Cork.
Eli Lilly is to invest €330m in a new hi-tech manufacturing facility at its Kinsale campus.
A further 300 people will be employed during the construction phase.
The investment will expand the Kinsale site with the establishment of an additional 240,000-square-foot commercialisation and manufacturing facility, the company said.
It is the second large investment made by the company in Cork in recent years.
In 2006, the company announced a €300m investment in its first biopharmaceutical manufacturing and new-product commercialisation facility at its Kinsale campus, which came onstream in 2010.
"Today’s announcement - that this world-leading company is making a substantial investment in expanding its facility in Kinsale with the creation of up to 200 permanent jobs- shows what is possible in these areas," said Jobs Minister Richard Bruton, making the announcement today.
“The Government is determined to ensure that more announcements like this become real in the coming years”, Minister Bruton added.
“By implementing the Action Plan for Jobs, we can support more businesses, rebuild the economy
and create the jobs we so badly need”.
Ed Canary, General Manager of the Kinsale site, said: "This investment is an endorsement of the Lilly Kinsale site’s success in developing a biopharmaceutical business in recent years and demonstrates our ability to rise to that challenge.
"This is in no small part due to the site’s excellent performance record, the talent of the workforce, and the support from IDA Ireland."
Headquartered in Indianapolis, Eli Lilly has been in Ireland for over 30 years and now employs around 700 people in four operations; in Kinsale, Cork City, Sligo and Dublin, involved in bulk pharmaceutical (API), biopharmaceutical manufacturing, animal vaccines, financial shared services, marketing and sales.
The Cork facility at Dunderrow, Kinsale, first established a manufacturing presence in Ireland in 1981 and manufactures the active ingredients for a number of Lilly’s most important medicines, including Alimta, Evista, Strattera, and Zyprexa.
Elsewhere in Cork today, Air cargo specialists Worldwide Flight Services Ireland opened a new state-of-the-art 465sqm depot at Cork Airport.
The expansion by WFS has allowed the company to employ five additional staff.
This has brought the total number employed by WFS Ireland to 45, with 32 based at a depot in Dublin Airport and a further eight based at a depot in Shannon.
Commenting at the opening of the new facility, Gerry Jackson, managing director, WFS Ireland said: “The opening of our new facility in Cork is the final step in our warehousing strategy and allows us to provide a faster and more efficient service to our many customers who are located within the Cork area.
“We can now offer the full WFS experience at all three major airports in Ireland whether the cargo is flown in to or out of these airports or trucked to and from the UK. We are also delighted to have been able to create five jobs here."